Dietmar Berger

Business address
C/O Atara Biotherapeutics, Inc., 611 Gateway Boulevard, Suite 900, South San Francisco, CA, 94080
Top holdings (ownership)
GILD
Get insider transactions for this reporting owner
Dietmar Berger has filed 9 SEC EDGAR filings since 07 May 2018

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT 12 Mar 2025 10 Mar 2025 000-19731
3 Open Document Open Filing FORM 3 10 Feb 2025 06 Feb 2025 001-38419
4 Open Document Open Filing PRIMARY DOCUMENT 03 Jan 2025 02 Jan 2025 000-19731
3 Open Document Open Filing PRIMARY DOCUMENT 03 Jan 2025 02 Jan 2025 000-19731
4 Open Document Open Filing FORM 4 SUBMISSION 08 May 2019 07 May 2019 001-36548
4 Open Document Open Filing FORM 4 SUBMISSION 27 Mar 2019 26 Mar 2019 001-36548
4 Open Document Open Filing FORM 4 SUBMISSION 08 Feb 2019 06 Feb 2019 001-36548
4 Open Document Open Filing FORM 4 SUBMISSION 07 May 2018 07 May 2018 001-36548
3 Open Document Open Filing FORM 3 SUBMISSION 07 May 2018 07 May 2018 001-36548